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1 INTRODUCTION 
 
Pesticides constitute a considerable fraction of large-scale products with world-
wide distribution and according to the US Environmental Protection Agency 
(EPA), almost a quarter of them contain a chiral center [GARRISON, 2006]. 
Many of these compounds such as pyrethroid-type insectides (α-cypermethrin, 
λ-cyhalothrin, β-cyfluthrin) or herbicides (glufosinate) are approved in Austria 
(RL 91/414 Appendix I).  
Stereochemistry plays a crucial role in determining the toxicological profile of 
many chiral xenobiotics as exemplified by the insecticide permethrin. The 
insecticidal (neurotoxic) action of mixtures containing the four stereoisomers of 
permethrin is essentially brought about by the (1R,cis)- and (1R,trans)-forms. 
As to the mode of action (MOA), permethrin interferes with the closure of 
voltage-sensitive sodium channels in both, insects and mammals. In addition to 
its neurotoxic action, permethrin may exert biological effects in other target 
cells/organs. For instance, permethrin has been reported to induce drug 
metabolizing enzymes and growth of rodent liver, it may also inhibit 
mitochondrial respiratory chain in hepatocytes [GASSNER et al., 1997; 
KOSTKA et al., 2000; HEDER et al., 2001], all of which are relevant endpoints 
in elucidating a chemical’s mode of action and toxicological risk assessment. 
However, no data on potential stereoselectivity of these permethrin hazards are 
available; the published studies on the induction of cytochrome P450 enzymes 
and inhibition of mitochondrial function were performed with four-isomer 
mixtures of permethrin only.  
Gathering information on stereochemistry-dependent biological effects of chiral 
pesticides is important for both regulatory as well as industrial decisions 
[KURIHARA et al., 1997]. The basic reasons for the separate testing of isomers 
and isomer-mixtures can be summarized as follows: 
(1) Isomers may possess different persistence in environment / exposed 
organism. 
(2) Isomers may have different effect profiles, both qualitatively and 
quantitatively. 
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(3) One isomer may modulate the toxicokinetic and -dynamic profile of the 
other(s). 
For example, if only one pesticide isomer exerts the desired effect (“eutomer”), 
while the other is essentially inactive (“distomer”), application of the isomer-
mixture leads to an increased environmental and in consequence, human 
burden due to the presence of “isomeric ballast” in the formulation. For 
example, chiral organophosphates and pyrethroids are two prominent classes 
of insecticides with high stereoselectivity in biodegradation and aquatic toxicity 
[LIU et al., 2005]. Hence, envisaging green chemistry it is rational to develop 
and apply appropriate isomer-containing formulations of chiral pesticides rather 
than isomer mixtures to maximize the ratio desired vs. undesired effects and to 
keep dosage and, thus, environmental and consumer load minimal. 
Taken together, it is obvious that the consideration of stereoselectivity in risk 
assessment of permethrin and related chiral pyrethroid burden is highly 
demanding [ALI et al., 2005].  However, regulatory guidelines for chiral 
pesticides are not yet as stringent as for chiral drugs and not at least due to this 
reason, the overwhelming number of chiral pesticides are still marketed and 
applied as isomer mixtures despite the (partial) knowledge about 
stereoselective biological fate and effects [MULLER et al., 2004; GARRISON, 
2006].  This issue is even more problematic as isomer-mixtures of permethrin 
are for example used in medical applications for humans and pets all over the 
world including Austria (Infectopedicul®, Lyclear®, etc.).  
An important prerequisite and common bottleneck in single stereoisomer testing 
is the availability of the respective compounds in highly purified form and 
stereochemical stability during the incubations. Both is fulfilled for permethrin as 
single stereoisomers are available in stereochemical purity exceeding 99 % 
[BICKER, 2006] and chiral centers are not considered susceptible to 
racemization. Need for individual stereoisomers of chiral pesticides by 
international health agencies which highlights the attention paid to chirality 
issues by competent authorities was recognized by the fact that the group of 
Prof. Dr. W. Lindner, University Vienna,  recently served as a supplier of 
individual permethrin stereoisomers for environmental monitoring studies of the 
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US EPA. Owing to the broad relevance of permethrin and due to the in-house 
availability of permethrin stereoisomers, a joint project of the Institute of Organic 
Chemistry/Christian Doppler Laboratory (Bicker, Lämmerhofer, Lindner, 
University of Vienna) and the Research Unit Toxicology and Prevention, Clinics 
of Medicine I, Institute of Cancer Research  (Bursch, Dornetshuber, Medical 
University of Vienna) was initiated to shed light on the stereoselectivity of non-
neurotoxic profile of permethrin and its stereoisomers. Constituting a part of this 
project, the present diploma thesis addresses two topics: 
1. the validity of newly established human hepatoma cell line HCC-1-2 for 
toxicological studies. 
2. the action of commercial [cis-racemate / trans-racemate ~ 25/75] and 
stereosisomers [(trans(+)-(1S,3R)- permethrin (11-permethrin); trans(-)-
(1R,3S) permethrin (12-permethrin); cis(-)-(1S,3S) permethrin (21-
permethrin); Cis(+)-(1R,3R) permethrin (22-permethrin)] on hepatocellular 
death (apoptosis). 
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2.1 Evaluation of the validity of the newly established human 
hepatoma cell line HCC-1-2 for toxicity studies. 
Since a long line of years, the toxicological research at the Institute of Cancer 
Research (ICR), Medical University of Vienna, is focused on liver growth 
regulation (cell proliferation, apoptosis) and its disturbance in chemical 
hepatocarcinogenesis. In the context of the present  diploma thesis, two of the 
prominent outcomes of toxicological research on rodents in vivo are briefly 
addressed: (1) Non-genotoxic hepatocarcinogens (liver tumor promoter such as 
sedatives, hypolipidemic drugs, hormones and environmental pollutants) favor 
cell multiplication and inhibit apoptosis, thereby accelerating 
hepatocarcinogenesis. (2) Transforming growth factor beta-1 (TGF-β1) 
constitutes a major death signal in rat liver, acting in concert with liver tumor 
promoter and nutritional factors to maintain liver cell number homeostasis 
[BURSCH et al., 2004]. 
Briefly, TGF-β1 is a member of a family of dimeric polypeptide growth factors 
that includes bone morphogenic proteins and activins [RODGARKIA-DARA et 
al., 2006]. TGF-β1 is a multi-functional cytokine involved in cell proliferation, 
differentiation, angiogenesis, motility, adhesion, and cell death [FLANDERS et 
al., 2001; M. O. LI et al., 2006; PRUD'HOMME, 2007; HOWE, 2003]. In the 
liver, TGF-β1 plays a key role in the regulation of homeostasis liver cell by 
inhibiting hepatocelluar proliferation and concomitantly, by inducing apoptosis; 
liver tumor promoting agents such as phenobarbital interfere  with mechanisms 
maintaining the balance between birth and death of cells (fig.2.1) 
[OBERHAMMER et al., 1991; BURSCH et al., 1993; MICHALOPOULOS, 2007].  
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Fig. 2.1 Regulation of birth and death of cells in the liver.  
The balance between replication and death of cells is tightly controlled according to the 
physiologcal needs of the organism. Some mitogenic factors also act as survival factors. 
Examples are transforming growth factor α (TGF-α), epidermal growth factor (EGF), or insulin-
like growth factors I and II (IGF I, II). Mitosis-inhibiting factors may induce cell death, for 
example, transforming growth factor β1, (TGF-β1), activin A and tumor necrosis factor 
(TNFα,β). A further important death signal is the ligand to the CD95 (= fas, Apo I) receptor. 
Tumor promoters interfere  with mechanisms maintaining the balance between birth and death 
of cells [RODGARKIA-DARA et al., 2006].  
 
In the context of the present study it should be noted that TGF-β1 expression in 
the liver may be also enhanced during certain stages of chemical liver injury, for 
instance upon intoxication with carbon tetrachloride, possibly providing an 
autocrine loop tuning the regenerative response of the liver to cell loss. TGF-β1 
regulates cellular processes by binding to three high-affinity cell-surface 
receptors known as types I, II, and III, signal-transduction involve Smad-
molecules, finally resulting in apoptosis execution via “intrinsic pathway” , see 
below; for review: [RODGARKIA-DARA et al., 2006].  
Concepts of cell death. The occurrence of cell death under a variety of 
physiological and pathological conditions in multicellular organisms has been 
documented many times during the past 160 years [CLARKE, 1990]. In 
pathology and toxicology, based upon the pioneering work of Rudolf Virchow in 
1850ies cell death (usually called “necrosis”) in living organisms traditionally 
was considered as a passive, degenerative phenomenon resulting from external 
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insults by numerous agents. This view of cell death was revolutionized in the 
early 1970ies by a group of British-Australian pathologists (John Kerr, Andrew 
Wyllie, Alistair Currie) proposing two broad cell death categories: 1. necrosis, 
resulting from massive cell injury and breakdown of cellular homeostasis [KERR 
et al., 1972; WYLLIE et al., 1980]. Morphologically necrosis is characterised by 
swelling of the cell and bursting its content in the area, which usually causes an 
inflammatory response.  2. The new term „apoptosis or programmed cell death 
was coined to describe an orchestrated collapase of a cell, staging membrane 
blebbing, cell shrinkage, chromatin condensation, DNA and protein degradation, 
accomplished by phagocytosis of corpses by neighbouring cells [KERR et al., 
1972; WYLLIE et al., 1980]. 
Apoptosis gained considerable credit when it became clear that it constitutes an 
essential part of life for any multicellular organism. Apoptotic cell death can be 
triggered by various death stimuli, including endogenous (physiological) death 
ligands as well as cytotoxic chemicals. Endogenous death ligands, for instance, 
comprise TGF-β1 (see above), tumor necrosis factor α (TNF-α), 
FasL/CD95/Apo1, and TNF-related apoptosis-inducing ligand (TRAIL). 
Chemical or chemotherapeutic agents inducing apoptosis, for instance, 
comprise organotin compounds, arsen, cisplatin, doxorubicin, 5-Fluoruracil, 
immunotoxins, antibodies [MEYERS et al., 2004; BILLINGSLEY et al., 2006; 
BREMER et al., 2006; VALKO et al., 2006]. Modern techniques provided 
insights into the molecular pathways triggered by such death stimuli; these 
revealed to be conserved from worm to mammals [DEGTEREV et al., 2008]. 
Thus, in a number of biological settings apoptosis involves the action of 
caspases (cysteine aspartic acid-specific proteases) as major players.  For 
instance, most of the stereotypic morphological features of apoptotic cells are 
brought about by caspases [LOCKSHIN et al., 2004a; LOCKSHIN et al., 2004b; 
I. LAVRIK et al., 2005a]. Caspases belong to a large family of highly conserved 
proteins that have been found in hydra, insects, nematodes and mammals; a 
number of them constitute a set of sequentially acting ‘‘initiator’’ and 
‘‘executioner’’ caspases, mediating a wide range of physiological and non-
physiological pro-apoptotic signals down to a final coordinated self-destruction 
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of the cell. To date, over 400 substrates for the effector caspases have been 
identified [CHANDRA et al., 2000; HAIL et al., 2006; LUTHI et al., 2007].  
Mitochondria constitute a major site for integration of diverse pro-apoptotic 
signals [“intrinsic pathway” via caspase-9 activation (apoptosome) as opposed 
to “extrinsic pathway”, triggered by activation of caspase-8 via death receptors 
of the TNF/NGF-family; both pathways join at the level of caspase-3 (fig. 2.2.) 
 [LAVRIK et al., 2005a; LAVRIK et al., 2005b].  The pro-apoptotic action of 
numerous stress signals incl. chemical agents has been shown to mediated to 
final cell death execution by the intrinsic pathway [BREMER & HELFRICH, 
2006; HETZ, 2007; LEMASTERS, 2007; FADEEL et al., 2008]. Apart from 
mitochondria the endoplasmic reticulum [PIZZO et al., 2007], lysosomes 
[STOKA et al., 2005] and the trans-Golgi-Network [NAKAGOMI et al., 2008] 
play important roles as well. Thus, each organelle possesses sensors that 
detect specific alterations, locally activates signal transduction pathways and 
emits signals that ensure inter-organellar cross-talk.  
Along with this gain in knowledge, however, morphological, biochemical and 
molecular observations revealed that active self-destruction of cells is not 
confined to apoptosis but cells may use different pathways to commit suicide, 
thereby severly challenging the initial necrosis-apoptosis dichotomy [CLARKE, 
1990; ZAKERI et al., 1995; KITANAKA et al., 1999; BURSCH, 2001; WYLLIE et 
al., 2001; YUAN et al., 2003; BURSCH, 2004; EDINGER et al., 2004; 
GOZUACIK et al., 2004; LOCKSHIN & ZAKERI, 2004a; LOCKSHIN & ZAKERI, 
2004b; SHINTANI et al., 2004; LEVINE et al., 2005; STEFANIS, 2005].  
For instance, cell death induced by apoptotic stimuli such as CD95-L or TNF 
exhibit hallmarks of necrosis under conditions of caspase-inhibition 
(“programmed necrosis”)   [YUAN et al., 2003; EDINGER & THOMPSON, 
2004]. Moreover, caspase-independent cell death may also ensue with the 
morphology of apoptosis [LOCKSHIN & ZAKERI, 2004a; LOCKSHIN & 
ZAKERI, 2004b]. Notably, early morphological and histochemical studies 
revealed no evidence for lysosomal or autophagic events in apoptotic cells in 
vivo [KERR et al., 1972; BURSCH et al., 1985; WYLLIE & GOLSTEIN, 2001]. 
To date, the autophagic-lysosomal compartment has been implicated in the 
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initiation of programmed cell death, either upstream or independent of caspase 
cascades, often denoted “type II programmed cell death” or “autophagic cell 
death” [SCHWEICHEL et al., 1973; CLARKE, 1990; ZAKERI et al., 1995; 
BURSCH, 2001; BURSCH, 2004; GOZUACIK & KIMCHI, 2004; LOCKSHIN & 
ZAKERI, 2004a; LOCKSHIN & ZAKERI, 2004b; ARTAL-SANZ et al., 2005]. 
In summary, it appears that diverse cell death programs emerged during 
evolution, the conservation of which apparently equips cells with a high degree 
of flexibility in assembling such elements to a cell death pathway according to 
the (patho)physiological conditions and needs.  
 
 
 
Fig. 2.2 Apoptosis: “Extrinsic” and “intrinsic” pathway to caspase activation 
[MACFARLANE et al., 2004].  
 
The extrinsic or caspase 8/10 dependent pathway is initiated by death receptors of the tumor necrosis 
factor–family (TNF-family).  Membrane-proximal caspases (caspase-8 and -10) are activated by ligation of 
transmembrane death receptors (like Fas/CD95, TNF receptor, and TNF-alpha related apoptosis-inducing 
ligand (TRAIL) receptor) with their respective ligands (FasL, TNF, and TRAIL). Ligand binding of the 
receptor causes the assembly of a series of proteins called the DISC (death-inducing signalling complex) 
which then activates procaspase-8 which in turn cleave and activate effector caspases such as caspase-3 
and –7. [I. LAVRIK et al., 2005a; I. N. LAVRIK et al., 2005b]. The intrinsic (mitochondrial) pathway of 
apoptosis functions in response to various types of intracellular stress and requires permeabilitation of the 
mitochondrial membrane and the release of mitochondrial proteins in the cytosol, such as cytochrome c 
which is normally confined in the mitochondrial intramembrane space. Once cytochrome c is released it 
binds with apoptotic protease-activating factor 1 (Apaf-1) and the presence of dATP, which then bind to 
pro-caspase-9 to create a protein complex termed apoptosome. The apoptosome cleaves the pro-
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caspase-9 to its active form, which in turn activates the effector caspase-3, to orchestrate the biochemical 
execution of programmed cell death [MACFARLANE & WILLIAMS, 2004; GOGVADZE et al., 2008; 
OBERST et al., 2008]. In addition, the release of cytochrome c from the intramembrane space, the 
intramembrane content released also contains for example apoptosis inducing factor (AIF) to facilitate 
DNA fragmentation, and Smac/Diablo proteins to inhibit the inhibitor of apoptosis (IAP)  [HAGUE et al., 
2004; GOGVADZE et al., 2008; OBERST et al., 2008]. 
The regulation of the intrinsic pathway is subjected to the control of proteins of the Bcl-2 family . 
Furthermore, agents that promote the mitochondrial permeability transition (MPT) such as ceramide, 
reactive oxygen species (ROS) or Ca2+ are key players in apoptosis execution  [HAIL et al., 2006]. 
 
Available liver cell culture models for studying the mode of action (MOA) 
of chemicals. To elucidate interactions (mode of action, MOA) of non-
genotoxic carcinogens with the complex growth regulatory network of the liver 
incl. cell death (apoptosis), along with the general need for alternative test 
models in toxicology, the research efforts at ICR aim to establish appropriate 
hepatocellular cell culture models that can be integrated into hazard and risk 
assessment for humans; for this purpose, an approach as schematically 
illustrated in figure 2.3 has been chosen. 
 
 
 
Fig. 2.3 Approach using knowledge on chemical structure along with animal experiments 
and cultured human cells for human hazard and risk assessment.  
 
Briefly, weighing validity of cell culture findings is guided by their concordance 
with in vivo observations. Thus, in a first step, based upon rat in vivo data, a 
Structure-Activity-Relationship 
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primary rodent hepatocyte culture system (incl. preneoplastic hepatocytes) 
was developed, followed by primary human hepatocyte culture [PARZEFALL 
et al., 1991; SCHULTE-HERMANN et al., 1999; LOW-BASELLI et al., 2000; 
PARZEFALL et al., 2002; SCHAUSBERGER et al., 2003; DRUCKER et al., 
2006]. These studies were complemented by investigations with established 
human hepatoma cell lines such as HepG2 and Hep3B [GÄRTNER, 2000; 
GRUSCH et al., 2006; BURSCH et al., unpublished results]. 
With regards to growth-regulation related endpoints and the need for 
standardized test conditions, the data revealed limitations of the investigated 
test systems. For instance, in primary hepatocyte cultures of rat or human 
origin, liver-specific functions are usually decreased and instable exhibiting 
variable and different changes with time in culture. Furthermore, use of primary 
human hepatocytes is limited by scarce and unpredictable availability, new 
donors are needed repeatedly, and considerable inter-individual variations do 
exist (for rats additional inter-species variations have to be considered). As to 
available human hepatoma cell lines, these are barely authenticated (no 
informed consent, few data on etiology and pathology) as well as ill 
characterized (may be even contaminated by other cells) and lack important 
functions of viable liver cells such as metabolic competence and the response 
to growth regulating cytokines. For instance, HepG2 and Hep3B have been 
found unsuitable for mimicking in vivo normal parenchymal cells as exemplified 
by their sensitivity to TGF-β1 and metabolic competence: HepG2 cells were 
resistant to TGF-β1-induced growth arrest and apoptosis [BUENEMANN et al., 
2001], but at least have retained little cytochrome P450 enzyme activity; on the 
other hand, Hep3B cells are sensitive to the pro-apoptoc action of TGF-β1 
[ROLIN et al., 1989; GRESSNER, 1998; HUANG et al., 1998; OGINO et al., 
2002; WILKENING et al., 2003]. 
Taken together, both primary human cells and current cell lines are not 
considered suitable for stringent standardized testing and, thus, deficiency of 
well-defined human hepatocytes culture systems / cell lines still constitutes a 
bottleneck for standardized compound testing according to REACH 
(Registration, Evaluation and Approval of Chemicals; European Community 
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Regulation on chemicals and their safe use (EC 1907/2006), entered into force 
on 1 June 2007). Most recently, Grasl-Kraupp and colleagues [SAGMEISTER 
et al., in press] succeeded in establishing a human hepatoma cell line (HCC-
1.2) and the first part of the present diploma thesis addresses the validity of 
HCC-1.2 cells as an alternative test system for hepatotoxicity. Based on the 
approach schematically shown in fig. 2.3, two questions were raised: 
 
1. Does TGF-β1 induce apoptosis of HCC-1.2 cells? 
2. Does the liver tumor promoter phenobarbital inhibit TGF-β1 induced 
apoptosis? 
 
According to the validation procedure schematically shown in fig. 2.3., a positive 
answer to these questions would render this cell culture model suitable to tackle 
questions concerning the hepatocellular toxicity of permethrin and its 
stereoisomers. 
 
 
2.2 Permethrin and cell death (apoptosis) in the liver 
 
2.2.1 Permethrin: chemical structure 
 
 
O
O
Cl
ClO 1 3
 
Fig. 2.4 Structure of Permethrin 
 
Permethrin [3-phenoxybenzyl (±) cis/trans-3(2,2-dichlorovinyl)-2,2-
dimethylcyclo-propane-1- carboxylate] is an insecticide and belongs to the 
group of pyrethroids. Pyrethroid insecticides are synthetic chemicals and similar 
to the natural pyrethrins contained in flowers of the genus Chrysanthemum. All 
pyrethroids are ester-containing compounds consisting of various acid and 
alcohol moieties. Permethrin and other pyrethroids with a basic cyclopropane 
2 STATE OF RESEARCH 
 
 
12 
carboxylic ester structure are classified as type I pyrethroids. Type II pyrethroids 
have additionally an alpha-cyano group [BRADBERRY et al., 2005].  
Owing two asymmetric substituted carbon atoms (stereogenic centres) in the 
cyclopropane ring system of permethrin four stereoisomers, two pairs of 
enantiomers (non-superimposable mirror images of each other) and two pairs of 
diastereoisomers (e.g. cis/trans isomerism) are possible. The two stereogenic 
centres are located in the 1 and 3 position of the cyclopropane ring. The spatial 
orientation of the C-3 subsitutients relative to the C-1 carboxylic acid moiety at 
the cyclopropane ring is either in cis or trans configuration. (fig. 2.4 is shows the 
cis configuration) 
Many of today’s permethrin formulations are marketed as four-isomer mixtures. 
Typical cis to trans ratios are 25:75 and 40:60 [RAY et al., 2006]. Permethrin is 
widely used for agricultural and domestic pest control and possesses relatively 
low acute mammalian toxicity and low environmental persistence. Although for 
agricultural applications the use of permethrin is now forbidden in Austria and 
other European countries, it is still widely employed for indoor pest control like 
in textiles such as carpets, wallpapers, furniture, and clothes as well as in 
human and veterinary medicine for the treatment of lice and scabies [MACAN et 
al., 2006]. 
2.2.2  Toxicokinetics   
 
Uptake of permethrin by humans predominantly ensues through ingestion, 
dermal absorption, or inhalation of dust or aerosol droplets; because of the very 
low volatility of pyrethroids, inhalation of vapour is of minor importance [RAY & 
FRY, 2006]. The initial biotransformation of permethrin (Phase I) involves attack 
by either esterases at the central ester bond or cytochrome P 450-dependent 
monooxygenases at the acid or alcohol moieties (fig. 2.5).  In rats, permethrin 
was hydrolyzed by carboxylesterase, the resulting alcohol moiety (3-
phenoxybenzyl alcohol (PBOH) was oxidized to 3-phenoxybenzaldehyde (not 
shown) and 3-phenoxybenzoic acid (PBA) by the cytochrome P450 system  
[NAKAMURA et al., 2007]. Notably, trans-isomers of permethrin are much more 
susceptible to esterase attack than cis-isomers [NAKAMURA et al., 2007]. 
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Further metabolism of these intermediate products involves conjugation 
reactions with amino acids, sugars, sugar acids or sulfate prior to excretion 
[IARC 53, 1991].  
 
 
Permethrin 
 
    
3-Permethrinic acid (PA)            3-Phenoxybenzyl alcohol (PBOH)  
      
 
 
3-Phenoxybenzoic acid (PBA) 
 
Fig. 2.5 Metabolites of permethrin in rat hepatocytes cultured identified by GC/MC 
analysis [HEDER et al., 2001]. 
 
Serum concentrations of permethrin peaked 3-4 hours after ingestion and then 
declined. Levels of the trans isomer were below the limits of detectability within 
25 hours after exposure, whereas cis-permethrin was still present at detectable 
levels 10 days after exposure. [SODERLUND et al., 2002]. 
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2.2.3 Toxicodynamics  
Permethrin, like all synthetic pyrethroids, kills insects by strongly exciting their 
nervous systems. The insecticidal action as affected by stereochemistry is 
shown in the following figure.  
 
 
 
Fig. 2.6 Acute Toxicity (LD50) of individual permethrin stereoisomers and racemic 
mixtures of cis and trans-permetrhin, respectively, towards the house fly (musca 
domestica). The “cis” and “trans” nomenclature refers to the spatial orientation of the 
substituent at C-3 in relation to the one at C-1 of the cyclopropane moiety [BICKER 2006]. 
 
As illustrated by fig. 2.6, LD50 values of permethrin towards Musca domestica 
(the amount of permethrin that kills 50 percent of a population within a given 
time frame) varies by almost a factor of 10 between the individual 
stereoisomers. Thus, 1R-isomers exert a much stronger insecticidal effect 
compared to the 1S-isomers; the insecticidal potency of racemic mixtures of the 
cis- and the trans- enantiomers is dominanted by the R-configuration (blue bars 
on the right). Overall, permethrin is toxic to honey bees and other beneficial 
insects, fish, aquatic insects, crayfish, and shrimp. For many species, 
concentrations of less than one part per billion are lethal. Permethrin causes 
deformities and other developmental problems in tadpoles, and reduces the 
number of oxygen-carrying cells in the blood of birds. 
In mammals, permethrin has complex effects on the nervous system as well. As 
in insects, it causes repetitive nerve impulses. It also inhibits a number of key 
molecules essential for homoeostasis of the nervous system: (a) the enzyme 
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ATPase, resulting in an increased release of the neurotransmitter acetylcholine; 
(b) monoamine oxidase-A, both enzymes are involved in neurotransmitter 
turnover; (c), GABA receptor, resulting in excitability and convulsions; (d) 
mitochondrial respiratory chain (for review: US-EPA 1997). Humans exposed to 
high doses exhibit symptoms including tremors, incoordination, elevated body 
temperature, increased aggressive behaviour, and disruption of learning. 
Laboratory tests suggest that permethrin is more acutely toxic to children than 
to adults. 
Mode of neurotoxic action.   Pyrethroids act on the axons of the peripheral 
and central nervous system of insects and mammals, with the voltage-sensitive 
ion channels (especially sodium) as primary targets. Voltage-sensitive sodium 
channels are responsible for the generation of the inward sodium current that 
maintains the action potential in most cells and are closed at normal resting 
potentials. Pyrethroids modify the gating characteristics of these channels and 
thereby delay their closure. Since sodium channels are held open longer, more 
sodium ions are allowed to cross and depolarize the neuronal membrane. Such 
a protected sodium influx can lower the action potential threshold and can 
cause repetitive firing of action potentials. This may be the mechanism of type I 
pyrethroids leading to paraesthesia and other syndromes like tremor, 
prostration, paralysis and eventual death [BRADBERRY et al., 2005; RAY & 
FRY, 2006]. Pyrethroids are much more neurotoxic to insects than to mammals 
because insects have a higher sodium channel sensitivity, a smaller body size 
as well as a lower body temperature. Moreover, mammals are specifically 
protected towards pyrethroid toxicity owing to a lower dermal absorption and a 
relative rapid and esterase-mediated biotransformation to non neurotoxic 
metabolites [BRADBERRY et al., 2005].  
Permethrin and cell death. Only a few studies were found addressing the 
effect of permethrin on cell death: screening the pubmed-database (05.06.2008) 
using the search term “permethrin” retrieved 1783 references,  but only 11 in 
combination with “cell death”. These studies cover neurotoxicity,  immuno-
toxicity and endocrine organ toxicity [ABDEL-RAHMAN et al., 2001¸ ABOU-
DONIA et al., 2003; PRATER et al., 2002; ABU-QARE et al., 2003; ABDEL-
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RAHMAN et al., 2004; GREENLEE et al., 2004; KAKKO et al., 2004; OLGUN et 
al., 2004; ELWAN et al., 2006]. For instance, as to the role of cell death for 
immunotoxic risks associated with multiple pesticide exposure, both apoptosis 
and necrosis of thymocytes were obsreved upon lindane, malathion, and 
permethrin, either separately or in mixtures of two pesticides [OLGUN et al., 
2004]. In rat brain, increased apoptosis was observed upon combined exposure 
to permethrin and the insect repellent DEET (N,N-diethyl-m-toluamide), but not 
upon permethrin alone; apoptosis was activated via release of mitochondrial 
cytochrome c (intrinsic pathway). None of the studies on permethrin and cell 
death addressed a potential selective action of its stereoisomers.  
Therefore, in the present study the effect of the commercial [cis-racemate / 
trans-racemate ~ 25/75] and the stereosisomers [(trans(+)-(1S,3R)- permethrin 
(11-permethrin); trans(-)-(1R,3S) permethrin (12-permethrin); cis(-)-(1S,3S) 
permethrin (21-permethrin); Cis(+)-(1R,3R) permethrin (22-permethrin)] on 
hepatocellular death (apoptosis) on cell death was investigated.  
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3 MATERIAL AND METHODS 
 
3.1 Chemicals and suppliers 
RPMI 1640 Sigma-Aldrich, Vienna, Austria 
TGF-β1  Eubio, Vienna, Austria 
BSA (Bovine Serum Albumin)  
Albumine Bovine Fraction Powder 
Sigma-Aldrich, Vienna, Austria 
DMSO Fluka, Buchs, Switzerland 
Phenobarbital Fluka, Buchs, Switzerland 
Rotenone Sigma-Aldrich, Vienna, Austria 
Permethrin (four isomer mixture) 
Permethrin-metabolites: 
3-permethrinic acid (PA) 
3-phenoxybenzyl alcohol (PBOH) 
3-phenoxybenzoic acid (PBA) 
Permethrin-stereoisomers, permethrin 
pure   
Agrochemia, Budapest, Hungary 
 
Agrochemia, Budapest, Hungary 
Fluka, Buchs, Switzerland 
Fluka, Buchs, Switzerland 
Dr. Wolfgang Bicker, Department of 
Analytical Chemistry and Food 
Chemistry, University Vienna, Austria 
 
Tab. 3.1 Chemicals and suppliers 
3.2 Cell culture 
3.2.1 Stock culture 
Human Hepatoma cell lines: HCC-1.2 and Hep3B 
When working with cells sterile and antiseptic conditions were maintained. Cell 
cultures were grown in sterile T75 bottles in the cell incubator at 37°C and  
5 % CO2. As growth medium the commercial available RPMI 1640 containing  
10 % FCS (fetal calf serum) and P/S (Penicillin/Streptomycin) was used. The 
growth medium (10-20 ml) was usually changed every second day. When 
confluence of the cells was reached, the cell culture was splitted, normally once 
a week.  
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Splitting of the cell culture: The RPMI (+ 10% FCS + P/S) medium was 
discarded and the T75 bottle was washed with 4 ml trypsin. Then the cells were 
incubated with 2.5 ml trypsin for 3 minutes in the incubator until they have 
detached from the bottom of the bottle. Immediately 10 ml RPMI + 10% FCS + 
P/S were added to neutralise trypsin and to stop the reaction. Afterwards the 
cell suspension was removed into 50 ml tubes and centrifuged for 5 min at 1500 
rpm. Subsequently, the pellet was resuspended with 5 ml RPMI + 10% FCS + 
P/S. Depending on the cell charge, the cells are reseeded 1:10 – 1:40 in T75 
bottles.  
3.3 Experimental Protocol 
3.3.1 Hepatoma cell line HCC-1.2 
Preparation (Fig. 3.1): For the apoptosis / mitosis assay, 1x105 cells were 
seeded in 3.5 Ø dishes for 24 hours in RPMI 1640-medium containing 10 % 
FCS to allow for recovery/attachment; for controls and in each experiment 2 
dishes were used. Subsequently, FCS was removed for 48 hours before 
commencing treatment with cytokines and/or permethrin.  
  
Fig. 3.1 Experimental protocol 
 
 
seed 
(1xE+5 cells per dish 
10% FCS) 
FCS withdrawal  
(0% FCS) 
cytokine /permethrin 
treatment 
         
0 24 
0 48 
0 48 24
0 120 hours 
investigation 
(apoptosis, mitosis etc) pretreatment  
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3.3.2 Hepatoma cell line Hep3B 
Hep3B cells were in general treated as described in “Hepatoma cell line HCC-
1.2”. However, cell density varies. For the apoptosis / mitosis assay 2x105 cells 
were seeded in 3.5Ø dishes. 
3.3.3 Primary hepatocyte cultures 
Reagents: 
Washing medium and William’s E medium was always prepared freshly before 
application. 
 
Washing medium (MEME) 
100 ml MEME 
1 ml Glutamax 
1 ml HEPES 
20 µl Tresylol 
100 µl Gentamycin 
 
William’s Medium E (WMEII) 
100 ml William’s Medium 
1,04 ml Glutamax 
1,04 ml Hepes 
1,04 ml Ascorbat 
1,04 ml H2 
104 µl Gentamycin 
 
Rat tail collagen 
The collagen was diluted 1:10 with H2Odd. 
Each dish was covered with 1,25 ml and dried over night. 
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SIP (Stock Isoosmotic Percoll) 
21,6 ml HBSS 
2,4 ml Percoll 
 
Male SPF Wistar rats obtained from the animal facilities of the Medical 
University of Vienna at the age of 3–4 weeks were used as donors. 
Hepatocytes were isolated by collagenase perfusion as described previously by 
Parzefall et al. 1989. Hepatocytes were collected from the initial cell suspension 
by centrifugation at 600 rpm for 5 minutes at 4°C. After the supernatant was 
discarded the pellet was resuspended with 20 ml MEME and centrifuged at 300 
rpm for 5 minutes (4°C). 25 ml of the resuspended cell suspension was mixed 
with 24 ml SIP (density: 1,06 g/ml) and centrifuged at 550 rpm for 10 minutes 
(4°C). The purified hepatocytes were washed twice with MEME: The 
supernatant was removed and the pellet was resuspended in 40 ml MEME and 
centrifuged at 550 rpm for 2 minutes (4°C).  Then the pellet was resuspended in 
25 ml MEME and centrifuged at 300 rpm for 5 minutes. Finally 20 ml MEME 
were added after the supernatant was discarded. Cell viability and total cell 
count were assessed by trypan blue index. 
Isolated hepatocytes were seeded in WMEII + 10 % FCS on plastic dishes 
covered with rat tail collagen at a density of 3x104 cells/cm2. The hepatocytes 
were allowed to attach to the collagen gel for 4 h. Treatment commenced after 
cells were twice washed with 1 ml MEME. The time of addition was defined 
“time point 0”.  After 30 and 44 hours cells were fixed and stained as described 
in histological determination of apoptosis and mitosis. 
3.3.4 Treatment of cell cultures 
 
Reagents 
 Stock solutions: 
TGF-β1 (Transforming Growth Factor-β1): 2.5 ng/µl (BSA) 
(dissolved in BSA) 
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After a quick spin 100 µl H2Odd were added to 5 µg recombinant human TGF-
β1. Afterwards the solution was diluted with 1,9 ml BSA (2 mg/ml) and 
transferred à 100 µl into tubes and stored at -20°C. 
BSA: 2 mg/ml  
(dissolved in H2Odd; stored at 4-7°C) 
Phenobarbital: 100 mM  
(dissolved in DMSO; stored at -20°C) 
Permethrin (four isomer mixture, stereoisomers and metabolites): 10 mM  
(dissolved in DMSO; stored at -20°C) 
Rotenone: 10 mM  
(dissolved in DMSO; stored at -20°C) 
 
For each cell culture dish 2 ml medium (RPMI + P/S) were used. TGF-β1 was 
applied in a concentration of 10 ng/ml. Phenobarbital was tested in the 
concentrations of 1 µM, 10 µM, 25 µM and 50 µM. Permethrin was applied in 
the concentrations of 25 µM and 50 µM, whereas experiments with the 
permethrin-stereoisomers were performed with 2 µM, 10 µM and 50 µM. For all 
permethrin metabolites a concentration of 50 µM was used. Rotenone was 
tested with the concentrations of 0,1 µM, 1 µM and 10 µM.  Immediately before 
application, permethrin, permethrin-stereoisomers, permethrin metabolites, 
phenobarbital and rotenone were diluted 1:200 in RPMI + P/S, thus the various 
final concentrations were dissolved in 0,5 % DMSO.  
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3.4 Histological determination of apoptosis and mitosis 
 
Reagents 
10 x PBS 
80g NaCl, 2g KCl, 18g Na2HPO4.1H2O and 2,4g KH2PO4 were added to 1000 
ml H2Odd and adjusted with NaOH to pH 7,4. Subsequently, 10 x PBS was 
autoclaved. 
 
4% Paraformaldehyde 
8% Paraformaldehyde was diluted 1:1 with 2 x PBS 
 
HOECHST  
10 x stock of bisbenzimide H33258 (80µg/ml H2Odd) 
Before the application the bisbenzimide H33258 stock was dissolved 1:10 in 1x 
PBS (8µg/ml). 
 
Geltol 
6g glycerol and 2,4g mowiol were added to 6ml H2Odd and soaked for ≥ 2 hours 
at room temperature. Then 12 ml 0,2M tris-Cl (pH 8,5) were supplemented and 
stirred for 10 minutes at 50°C. Finally, the solution was centrifuged at 3000 rpm 
for 15 minutes. 
 
After the RPMI 1640 + P/S medium was removed and the cells were fixed with 
1 ml 4% paraformaldehyde per dish for 10 min at RT. The dishes were washed 
2 times with 1 ml 1x PBS. Subsequently, the cells were stained with HOECHST 
(1:10 dilution in 1x PBS) for 10 min, followed by 2 further washing steps with 1x 
PBS. The dishes were dried in the dark, the dish plates were cut out and 
covered with 12 µl geltol. The plates were left in the dark over night until 
analysis by microscopy.   
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3.4.1 Morphological Evaluations 
Chromatin was stained with the DNA-specific stain H33258. Chromatin 
condensation and fragmentation indicative of apoptosis as illustrated in fig. 3.2 
were counted for quantitative analysis of apoptosis scoring 500-1000 cells per 
dish. 
 
             a                b             c 
Fig. 3.2  Morphology of HCC-1.2 treated with TGF-β1. Fluorescence microscopy (40x) of 
H33258 staining. (a) Control: intact chromatin, (b and c) condensation and fragmentation 
of the chromatin. 
 
3.5 Statistical analysis 
 
Statistical analysis was performed with the software InStat (Version 3.06, 
created 2003). All data were examined for normality by Kolmogorov Smirnov-
Test. Statistical differences for data which passed the normality test were 
evaluated using the One-way Analysis of Variance (ANOVA) and Tukey-Kramer 
Multiple Comparisons Test whereas data which deviated from normality were 
compared with Kruskal-Wallis Test (Nonparametric ANOVA) and Dunn’s 
Multiple Comparisons Test. The P value < 0.05 was considered significant.  
(*** = P < 0.001; ** = P< 0.001; * = P<0.05) 
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4 RESULTS  
4.1 Functional characterisation of human hepatoma cell lines 
(HCC.1-2, Hep3B) and primary rat hepatocytes based upon 
sensitivity to TGF-β1 and phenobarbital 
 
4.1.1  Human hepatoma cell line HCC-1.2 
 
A first series of experiments aimed at elucidating whether the newly established 
human hepatoma cell line HCC-1.2 [SAGMEISTER et al., in press], would 
exhibit a sufficient concordance with in vivo observations on the role of 
Transforming Growth Factor beta 1 (TGF-β1) and liver tumor promoter in 
regulation of liver cell proliferation and apoptosis, namely    
(1) a high sensitivity towards the anti-proliferative and pro-apoptotic action of 
TGF-β1;  
(2) the inhibition of TGF-β1- induced apoptosis by liver tumor promoter, as 
exemplified by phenobarbital. 
 
4.1.1.1 Effect of TGF-β1 on apoptosis, mitosis and cell density  
 
The apoptotic response of HCC-1.2 cells to TGF-β1 (10 ng/ml) was 
determined morphologically at 24 hours and 48 hours after treatment. As shown 
in fig. 4.1 a, the basal (control) apoptotic activity was about 1.5 – 2 % at 24 and 
48 hours. TGF-β1 (10 ng/ml) caused an increase in apoptoses to about 7 % at 
24 hours, followed by further enhancement to approximately 11 % at 48 hours 
after treatment. To account for variances of the basal apoptotic activity among 
the individual experiments, apoptoses of 24 hour controls were set as 1 and 
those of 48 hour controls as well TGF-β1 treated cell cultures were expressed 
as x-fold change. As shown in fig. 4.1 b, essentially the same results were 
obtained.  
4 RESULTS 
 
 
25
The mitotic activity of control cultures declined significantly with time (fig. 4.2. 
a; P< 0.001 48 vs. 24 hours).  At both time points of investigation, TGF-β1 
caused an approximately 30 % inhibition of mitosis.  Again, essentially the same 
results were obtained when mitosis were expressed as “x-fold of 24 hour 
control” (fig. 4.2 b). 
As a result of the pro-apoptotic and the anti-mitotic action of TGF-β1 on HCC-
1.2 cells, cell density progressively declined by approximately 30 % at 24 
hours and by about more than 50 % at 48 hours after TGF-β1 (fig. 4.1 e). 
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Fig. 4.1 Effect of TGF-β1 on apoptosis, mitosis and cell density of HCC-1.2 cell cultures  
10 ng/ml TGF-β1. Time points of investigation: 24 h and 48 h. (a, b) apoptosis;  
(c, d)  mitosis; (e)  cell density (number of cells per microscopic field). Means (±SD) of 12-15 
4 RESULTS 
 
 
26 
experiments are shown; numbers are listed in appendix, table 1. Statistical comparisons: (a, c, 
d, e) ***P<0.001, **P<0.01 using Dunn's Multiple Comparisons, Co vs. TGF-β1; (b) ***P<0.001 
using Tukey-Kramer Multiple Comparisons Test, Co vs. TGF-β1.  
 
4.1.1.2 Effect of phenobarbital on TGF-β1 induced responses: apoptosis, 
mitosis and cell density  
 
A prominent feature of liver tumor promoter such as phenobartital is to inhibit 
apoptosis of hepatocytes and thereby, to accelarate development of frank 
neoplasia in rat liver [BURSCH et al., 1984; SCHULTE-HERMANN et al., 1990], 
most likely in a concerted action with cytokines of the transforming growth 
factor-beta family [RODGARKIA-DARA et al., 2006]. Consequently, HCC-1.2 
cells were probed for their sensitivity to phenobarbital as inhibitor of TGF-β1 
induced apoptosis.  
In fact, a time- and dose-dependent inhibitory effect was found (fig. 4.2 a): a 40-
50 % inhibition of TGF-β1 induced apoptosis, though not significant, occurred 
at 24 hours after treatment with 25 µM to 50 µM phenobarbital (fig. 4.2 b). A 
more pronounced inhibitory effect (P<0.001) became obvious at 48 hours after 
phenobarbital-treatment (fig. 4.2 a, b). Again, essentially the same results were 
obtained when apoptosis where expressed as “x-fold of 24 hour control”.  
 
As to mitosis and cell death density, phenobarbital did not produce a significant 
effect but revealed a consistent trend to increase both, mitoses and the average 
cell count per microscopic field in TGF-β1 treated cultures (fig. 4.2 d, e).  
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Fig. 4.2 Effect of phenobarbital onTGF-β1 induced response: apoptosis mitosis and cell 
density of HCC1.2 cell cultures 
10 ng/ml TGF-β1; 1 µM, 25 µM and 50 µM PB (phenobarbital). Time points of investigation: 24 
h and 48 h. (a, b) apoptosis; (c, d) mitosis; (e) cell density (number of cells per microscopic 
field). Means (±SD) of 2-6 experiments are shown; numbers are listed in appendix, table 8.2. 
Statistical comparisons:  (a) ***P<0.001 using Tukey-Kramer Multiple Comparisons Test, TGF-
β1 vs. PB+TGF-β1, (b, c, d, e) using Dunn's Multiple Comparisons, TGF-β1 vs. PB+TGF-β1.  
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4.1.2  Hep3B cells: Effect of TGF-β1 and phenobarbital on 
apoptosis, mitosis and cell density 
 
In a second step, the experiments with the newly established HCC-1.2 cells 
were supplemented by studies with a human hepatoma cell line widely used by 
the scientific community since many years, namely Hep3B.  
Treatment of Hep3B-cells with TGF-β1 caused a significant increase in 
apoptotic activity at 24 and 48 hours (Fig 4.3 a), i.e. 3.1 and 2.1-fold, 
respectively (fig 4.3 b). Furthermore, 50 µM phenobarbital alone tended to 
increase apoptosis of Hep3B cells but produced a significant inhibition of TGF-
β1 induced apoptosis (approximately 55 % at 24 and 48 hours, 4.3.a).  
Mitotic activity of Hep3B tended to be reduced after TGF-β1 treatment and 
somewhat more pronounced upon combined treatment with TGF-β1 plus 
Phenobarbital, but none of the differences was significant (fig. 4.3 c, d). As a 
result, cell density appears to grossly meet with apoptotic activity (fig.4.3 e).  
 
In summary, TGF-β1 exhibited a pro-apoptotic action on Hep3B cells which, 
however, was less pronounced as compared to HCC-1.2 (cf. fig. 4.3 b, 4.1 b). 
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Fig. 4.3 Hep3B cells: Effect of TGF-β1 and phenobarbital on apoptosis, mitosis and cell 
density. 
10 ng/ml TGF-β and 50 µM PB (phenobarbital). Time points of investigation: 24 h and 48 h. (a, 
b) apoptosis; (c, d) mitosis; (e) cell density (number of cells per microscopic field). Means (±SD) 
of 1-2 experiments are shown; numbers are listed in appendix, table 8.3. Statistical 
comparisons:  a) P<0.05, Co vs. TGF-β1; b)TGF-β1vs. PB+TGF-β1 using Tukey-Kramer Multiple 
Comparisons Test.  
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4.1.3  Primary rat hepatocytes: Effect of TGF-β1 and 
phenobarbital on apoptosis, mitosis and cell density 
 
In a third step, the experiments with human hepatoma cells were supplemented 
by studies with primary hepatocytes as a model for healthy cells. Primary rat 
hepatocytes are known to be highly sensitive to TGF-β1 and based on previous 
findings from [OBERHAMMER et al., 1991] cultured primary rat hepatocytes 
were treated with 3 ng/ml TGF-β1.  
The apoptotic activity in primary rat hepatocyte culture remained at a low level 
of about 0.5 % at 30 and 44 hours, respectively (fig. 4.4 a). TGF-β1 (3 ng/ml) 
led to a significant increase in apoptotic nuclei to about 7.5 % and 5 % at 30 
and 44 hours, respectively (fig. 4.1 a).  Furthermore, addition of 50 µM 
phenobarbital significantly (P <0.001) antagonized the pro-apoptotic action of 
TGF-β1 (inhibition by approximately 40-45 %, fig. 4.4 a). Essentially the same 
response pattern was obtained when the data were expressed as “x-fold of 24 
hour control”. 
As to mitosis, control hepatoycte cultures displayed 0.15 % mitotic cells, which 
was considerably less compared to HCC-1.2 cell cultures with mitosis levels of 
approximately 2.5%. Treatment of primary rat hepatocyte cultures with 
phenobarbital and TGF-β1, either alone or in combination, did not significantly 
affect mitotic activity (fig. 4.4 e). The low mitotic activity is typical of primary 
hepatocyte cultures, even upon stimulation with liver mitogenes such as 
epidermal growth factor [PARZEFALL et al., 1989]. Consequently, cell density 
as measured at 48 hours after TGF-β1 or phenobarbital-treatment appeared to 
be determined predominantly by apoptotic activity (fig. 4.4 e).  
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Fig. 4.4 Primary rat hepatocytes: Effect of TGF-β1 and phenobarbital on apoptosis, 
mitosis and cell density 
10 ng/ml TGF-β and 50 µM PB (phenobarbital). Time points of investigation: 30 h and 44 h. (a, 
b) apoptosis; (c, d)  mitosis; (e)  cell density (number of cells per microscopic field). Means 
(±SD) of 2 experiments are shown; numbers are listed in appendix, table 8.4. Statistical 
comparisons:  a) P<0.01, Co vs. TGF-β1; b)TGF-β1vs. PB+TGF-β1 using Tukey-Kramer Multiple 
Comparisons Test.  
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4.2 EFFECT ON PERMETHRIN AND ITS STEREOISOMERS ON 
HUMAN HEPATOMA CELLS (HCC.1-2, Hep3B) AND PRIMARY 
RAT HEPATOCYTES 
 
4.2.1  Effect of stereoisomer mixture on apoptosis, mitosis and cell 
density of HCC1.2 cells. 
 
First, a commercial mixture consisting of about 25 % cis-permethrin and 75 % of 
trans-permethrin racemate (chemical purity ~96% as determined by HPLC) was 
tested. As shown in fig. 4.5 a, 25 µM and 50 µM permethrin alone led to a  
2-3 fold, but statistically insignificant, increase in apoptosis at both time points of 
investigation. TGF-β1 exerted a pro-apoptotic activity as in the previous 
experiments (approximately 5-fold above control), which was further enhanced 
by combined treatment with 25 or 50 µM permethrin (about 10 fold above 
control; Fig. 4.5 b).  
As to mitosis, permethrin, with and without TGF-β1, tended to inhibit mitosis.  
As a result of its pro-apoptotic, along with the less pronounced anti-mitotic 
action, permethrin caused a significant loss in the average cell count per 
microscopic field (fig. 4.5 d). 
In conclusion, commercial permethrin possesses a pro-apoptotic action on 
HCC-1.2 cells, along with a weak anti-mitotic activity. Notably, as illustrated in 
fig 4.6, the pro-apoptotic action of permethrin was found to be additive to that of 
TGF-β1.  
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Fig. 4.5 Effect of commercial permethrin on apoptosis, mitosis and cell density in HCC-
1.2 cultures. 
10 ng/ml TGF-β1; 25 µM and 50 µM permethrin (Per). Time points of investigation: 24 h and 48 
h. (a, b) apoptosis; (c)  mitosis; (d)  cell density (number of cells per microscopic field). Means 
(±SD) of 4-10 experiments are shown; numbers are listed in appendix, table 8.5. Statistical 
comparisons:  a) P<0.05, Co vs. TGF-β1; b) P<0.05 TGF-β1vs. Per+TGF-β1 c) P<0.01, Co vs. 
Per+TGF-β1, (a, b, d) using Dunn's Multiple Comparisons Test and (c) Tukey-Kramer Multiple 
Comparisons Test. 
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Fig. 4.6 Additive effect of 50µM permethrin and 10 ng/ml TGF-β1 after 24 hours. 
(I: Per alone = A; II: TGF-β1 alone = B;  III: Per + TGF-β1 ≈ A+B) 
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4.2.2 Potential effect of chemical impurities of commercial permethrin on 
apoptosis of HCC-1.2 cells 
 
To check for the possibility that chemical impurities of the commercial 
permethrin might contribute to the pro-apoptotic effect, the commercial lot was 
purified by HPLC (chemical purity > 99 %) and subjected to the same test 
protocol as the non-purified material. As shown in Fig. 4.7 no significant 
differences between commercial and purified permethrin were found at 24 and 
48 hours after treatment, with or without TGF-β1. Thus, commercial permethrin 
proved to be a suitable positive control for subsequent experiments with purified 
stereoisomers of permethrin. 
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Fig. 4.7 Potential effect of chemical impurities of commercial permethrin on apoptosis of 
HCC-1.2 cells  
10 ng/ml TGF-β1, 25 µM and 50 µM commercial permethrin (Per; dotted columns), pure 
permethrin (pPer; white columns), respectively. Time points of investigation: 24 h (a, b) and 48 
h (c, d). Means (±SD) of 2 experiments are shown; numbers are listed in appendix, table 8.6. No 
significant differences using Tukey-Kramer Multiple Comparisons Test Per vs. pPer.  
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36 
4.2.3 Effect of permethrin on TGF-β1-induced apoptosis of human 
hepatoma cells Hep3B and primary rat hepatocytes 
 
In a further series of experiments, the pro-apoptotioc effect of permethrin on 
HCC-1.2 was compared Hep3B cells and to primary rat hepatocytes. 
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Fig. 4.8 Effect of permethrin on apoptosis of human hepatoma cells Hep3B and primary 
rat hepatocytes 
Effect of 50 µM permethrin (Per) and 10ng/ml TGF-β1 in HCC-1.2 and Hep3B cells after 24 
hours (a, b) and 48 hours (c, d). Effect of 50 µM permethrin (Per) and 3ng/ml TGF-β1 in primary 
rat hepatocytes after 30 hours (a, b) and 44 hours (c, d). Means (±SD) of 1-10 experiments are 
shown; numbers are listed in appendix, table 8.7. Statistical comparisons: HCC-1.2: ***P<0.001 
using Dunn's Multiple Comparisons Test, TGF-β1 vs. Per+TGF-β1. Hep3B and primary rat 
hepatocytes: **P<0.01 using Tukey-Kramer Multiple Comparisons Test, TGF-β1 vs. Per+TGF-
β1. 
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HCC-1.2 cells responded to TGF-β1 and permethrin as in previous 
experiments. As to Hep3B cells, permethrin alone (50 µM) tended to enhance 
apoptotic activity and TGF-β1 caused a moderate increase in apoptosis; 
combined treatment of TGF-β1 and permethrin did not alter the moderate pro-
apoptotic action of TGF-β1. Furthermore, in cultured primary rat hepatocytes 
permethrin alone (50 µM) did not affect apoptotic activity as compared to 
controls. In combination with TGF-β 1, permethrin caused at most a slight (20%) 
enhancement of apoptoses after 24 hours (fig. 4.8b), a seemingly more 
pronounced effect of combined treatment resulted at 48 hours. However, the 
data available at present do not allow a final conclusion, further studies incl. 
more than two time points are required.  
  
4.2.4 Stereoselective apoptotic effects of permethrin  
 
Stereoisomers of permethrin [(trans(+)-(1S,3R)- permethrin (11-permethrin); 
trans(-)-(1R,3S) permethrin (12-permethrin); cis(-)-(1S,3S) permethrin (21-
permethrin); Cis(+)-(1R,3R) permethrin (22-permethrin); enantiomeric excess 
> 99 % each, chemical purity > 99 % each] were tested with HCC-1.2 cells at 
concentrations of 2 µM, 10 µM and 50 µM for 24 hours, with or without TGF-β1. 
For comparison, cells were treated with commercial permethrin (cis-racemate / 
trans-racemate ~ 25/75). 
As shown in fig. 4.9, HCC-1.2 cells responded to TGF-β1 and 50 µM 
commercial permethrin as in the previous experiments (cf. fig. 4.5 a, b). 
Treatment with 2 µM, 10 µM and 50 µM of the individual permethrin 
stereoisomers for 24 hours revealed a dose dependent pro-apoptotic effect (fig. 
4.9 a-d). 50 µM of each isomer exhibited the same pro-apoptotic potency as the 
the equimolar concentration of the commercial formulation.  
In the presence of TGF-β1, the stereoiosomers exhibited a dose-dependent 
additive pro-apoptotic action, becoming manifest at 10 µM and statistically 
significant, at 50 µM of either isomer (fig. 4.9. a-d). 
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Fig. 4.9 Stereoselective apoptotic effects of permethrin 
HCC-1.2 treated with 10 ng/ml TGF-β1, 50 µM commercial permethrin, 2µM, 10µM and 50 µM 
permethrin-stereoisomers. Time point of investigation: 24h. Means (±SD) of 2-3 experiments are 
shown; numbers are listed in appendix, table 8.8. Statistical comparisons:  
(b) **P<0.01 Co vs. 50µM 12-Per; ***P<0.001 TGF-β1 vs. 50µM 12-Per+TGF-β1. 
(c) **P<0.01 Co vs. 50µM 21-Per; ***P<0.001 TGF-β1 vs. 50µM 21-Per+TGF-β1. 
(d) *P<0.05 TGF-β1 vs. 10 µM 22-Per+TGF-β1; **P<0.01 TGF-β1 vs. 50µM 12-Per+TGF-β1. 
using Tukey-Kramer Multiple Comparisons Test. 
 
 
As to potential differences in the pro-apoptotic potency among the 
stereoisomers, the data as plotted in fig. 4.10 revealed neither consistent nor 
significant differences between 11, 12, 21 and 22 permethrin. These 
investigations demonstrated that, in contrast to the pronounced differences in 
the insecticidal (neurotoxic) action of permethrin stereoisomers (isomers with 
1R-configuration being most effective, cf. Figure 2.2), the pro-apoptotic action of 
permethrin does not depend on steroisomeric properties of the chemical.  
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Fig. 4.10 Same data as shown in fig. 4.9. For easier comparison, columns of for each 
stereoisomer are juxtaposed. Statistical comparisons: see fig. 4.9. 
 
 
4.2.5 Effects of permethrin metabolites 
Finally, to check whether phase I metabolism of permethrin to 3-permethrinic 
acid (PA), 3-phenoxybenzyl alcohol (PBOH) and 3-phenoxybenzoic acid (PBA), 
respectively, might modulate the pro-apoptotic action of permethrin, 
complementary investigations were carried out with these three compound. As 
reference substances 50µM phenobarbital, 50µM permethrin and 1µM rotenone 
were applied. Phenobarbital served as reference to take into account potential 
inhibitory effects of the metabolites, rotenone potential pro-apoptotic effects of 
metabolites. Retonone was choosen as it known to induce apoptosis of HL-60 
cells, involving mitochondrial production of  ROS as anticipated for permethrin 
(see discussion, 5.2.) [N. LI et al., 2003]. In a preliminary, dose-finding 
experiment HCC-1.2 cells were tested for rotenone sensitivity. As shown in fig. 
4.11 rotenone showed a dose and time dependent induction of apoptosis; the 
concentration of 1µM was chosen for the subsequent experiments with 
permethrin metabolites.  
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Fig. 4.11 Response of HCC-1.2 to 0,1 µM, 1 µM and 10 µM rotenone (R) and 10 ng/ml  
TGF-β1. 
Time point of investigation: 24h and 48h. Data of individual cell cultures of one experiment are 
shown; numbers are listed in appendix, table 8.9.  
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Fig. 4.12 Effects of permethrin metabolites 
HCC-1.2 treated with 10 ng/ml TGF-β1, 50 µM permethrin, 50 µM phenobarbital, 1 µM 
rotenone, 50 µM 3-permethrinic acid (PA), 50 µM 3-phenoxybenzyl alcohol (PBOH) and 50 µM 
3-phenoxybenzoic acid (PBA). Time point of investigation: 24h and 48h. Means (±SD) of 3 
experiments are shown; numbers are listed in appendix, table 8.10. Statistical comparisons:   
a)P<0.05 Co vs. TGF-β1; b)P<0.01 TGF-β1 vs. TGF-β1 + Per; c)P<0.05 TGF-β1+Per vs. TGF-β1 
+ metabolites; d)P<0.01 Co vs. Rotenone, no significant differences of “TGF-β1 alone” vs. TGF-
β1 + metabolite” as well as among the metabolites were found using (a, b, c) Tukey-Kramer 
Multiple Comparisons and (d) Dunn's Multiple Comparisons Test.   
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All permethrin metabolites, along with the parental compound, were tested at 
the concentration of 50 µM, with and without TGF-β1, at 24 and 48 hours after 
treatment (fig. 4.12 a-d). In this experimental series permethrin alone caused an 
approximately 2-fold, TGF-β1 about 4-fold induction of apoptoses (fig. 4.11). 
Again, the combination of both resulted in an additive effect (fig. 4.11), i.e. an 
about 8-fold enhancement of apoptotic activity. The permethrin metabolites PA, 
PBOH and PBA, alone or in combination with TGF-β1, exhibited a less, if any, 
pro-apoptotic activity as compared to parental permethrin. Essentially the same 
response pattern was observed at 24 and 48 hours after treatment (4.12 a, b vs. 
4.12 c, d). In conclusion, hydrolysis of the ester-bond appears sufficient for 
greatly reducing the pro-apoptotic potency of permethrin. 
 
 
 
 
 
5 DISCUSSION 
 
 
42 
5 DISCUSSION 
 
5.1 Evaluation of HCC-1-2 cells as test system for toxicological 
studies 
Previous in vivo studies revealed TGF-β1 as a major player in liver growth 
regulation in rats, namely acting as inhibitor of cell birth and inducer of cell 
death [OBERHAMMER et al., 1991; BURSCH et al., 1993; SCHULTE-
HERMANN et al., 1995; RODGARKIA-DARA et al., 2006]. Furthermore, TGF-
β1 induced apoptosis was found to ensue via the intrinsic pathway as 
demonstrated by caspase analysis in vivo [ECKLE et al., 2004]. These in vivo 
findings were supported by  studies on primary hepatocyte cultures  
[OBERHAMMER et al., 1991; BURSCH et al., 1993; SCHULTE-HERMANN et 
al., 1995; RODGARKIA-DARA et al., 2006]. The first series of experiments the 
newly established human hepatoma cell line HCC-1.2 confirmed and extended 
these observations (table   5.1). 
 
Tab. 5.1  Response of liver cells in vivo and in cell culture to TGF-β1 and Phenobarbital 
 
Parameter In vivo (rat) 
Primary rat 
Hepatocytes HCC-1.2 Hep3B 
TGF-β1: 
inhibition cell 
proliferation 
+ n.d. + n.d. 
TGF-β1: 
induction of 
apoptosis 
+ + + + 
Apoptosis via 
the intrinsic 
pathway 
+ n.d. + n.d. 
Inhibition of 
TGF-β1-induced 
apoptosis by 
Phenobarbital 
+ + + + 
 
 
5 DISCUSSION 
 
 
43
Briefly, HCC-1.2 cells revealed a high sensitivity towards the pro-apoptotic 
action of TGF-β1. In addition, TGF-β1 exhibited an anti-mitotic effect on HCC-
1.2 cells. As to the cellular mechanism of apoptosis execution, Western blot 
analysis revealed cleavage of caspase 3 and 9, but not of caspase 8 in HCC-
1.2 cells [KARWAN et al., 2007; BURSCH et al., 2008]. Thus, TGF-β1 induced 
apoptosis of HCC-1.2 cells ensues via the intrinsic pathway as in vivo [ECKLE 
et al., 2004]. 
A prominent feature of liver tumor promoter such as phenobartital is to inhibit 
apoptosis of hepatocytes and thereby, to accelarate development of frank 
neoplasia in rat liver [BURSCH et al., 1984; SCHULTE-HERMANN et al., 1990], 
most likely in a concerted action with cytokines of the transforming growth 
factor-beta family [RODGARKIA-DARA et al., 2006]. Likewise, phenobarbital as 
well as another liver tumor promoter, 2,3,7,8-Tetrachlorodibenzodioxine, 
inhibited UV-induced apoptosis in primary rat hepatocytes cultures 
[BOHNENBERGER et al., 2001; SCHRENK et al., 2004]. The present study 
confirmed and extended these observations showing that phenobarbital 
inhibited TGF-β1 induced apoptosis of hepatoma cells (HCC-1.2, Hep3B) in a 
dose-dependent manner. 
Furthermore, the pro-apoptotic effect of TGF-β1 on HCC-1.2 cells were 
compared with that on primary rat hepatocytes and the human hepatoma cell 
line Hep3B. In all cell types tested, TGF-β1 exerted a pro-apoptotic action; the 
pro-apoptotic activity was more pronounced in cultured primary rat hepatocytes 
than in HCC-1.2 and in Hep3B cells at both after 24 hours and 48 hours. 
Taken together, the responses of HCC-1.2 cells to TGF-β1 and phenobarbital 
are highly concurrent with previous in vivo-observations. Furthermore, TGF-β1-
induced apoptosis of the cultured hepatoma cells ensue via the intrinsic 
pathway, the identical pathway activated by normal (healthy) and preneoplastic 
hepatocytes in vivo [ECKLE et al., 2004]. In view of validating toxicological test 
systems, the higher sensitivity of primary rat hepatocytes to the pro-apoptotic 
action of TGF-β1 as compared to HCC-1.2 cells is considered to be 
counterbalanced by the advantage of using a cell line of human origin and (b) 
by reducing the use animals (hepatocyte donors).  In conclusion, HCC-1.2 cells 
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provide a valuable test system for cell cultures tackling to questions such as on 
toxicity of permethrin, permethrin-stereoisomers and permethrin-metabolites. 
5.2 Studies on permethrin  
 
The present study revealed that the four-isomer mixture of commercial 
permethrin [cis-racemate / trans-racemate ~ 25/75; 25 and 50 µM] exerted pro-
apoptotic action at 24 and 48 hours after treatment of HCC-1.2 cells and 
somewhat less pronounced, Hep3B cells. Cultured primary rat hepatocytes 
cells, however, revealed no apoptotic response to permethrin under the 
experimental conditions used (50µM, 24 and 48 hours). 
Likewise, the four isomer mixture of permethrin induced apoptosis in murine 
SK-DAT cells [ELWAN et al., 2006] and in murine thymocytes [PRATER et al., 
2002]. Combined exposure of permethrin along with pyridostigmine-bromide 
(anti-nerve gas drug) and N;N-diethyl m-toluamide (DEET; insect repellent) 
caused apoptosis in testicular germ-cell in stressed rats; this kind of study was 
performed because military personnel was exposed to such a combination 
during the Persian Gulf War [ABOU-DONIA et al., 2003]. The pesticide mixture   
lindane, malathion and permethrin (reflecting agricultural exposure scenarios) 
induced apoptotic and necrotic cell-populations in murine thymocytes [OLGUN 
et al., 2004]. 
In the present study, permethrin was tested in combination with TGF-β1. As 
outlined above, TGF-β1 possibly provides an autocrine loop tuning the 
response of the liver to chemical injury. Thus, the approach of combining 
permethrin with TGF-β1 as used in the present study represents the 
combination of a potentially cytotoxic agent with an endogenous growth 
regulating cytokine. The series of experiments on combined treatment of 
permethrin (50 µM) with TGF-β1 (10 ng/ml) revealed an additive effect on 
apoptosis in HCC-1.2 cells, but only a weak in Hep3B or even none in primary 
rat hepatocyte cultures. The causes underlying this differential sensitivity are 
not yet elucidated. 
Notably, as commercial permethrin (cis-racemate / trans-racemate ~ 25/75) was 
used in the first series of experiments, the potential effect of impurities on 
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apoptosis has to be taken into account. Consequently, HPLC-purified fractions 
(purity > 99 %) of the commercial permethrin were tested for pro-apoptotic 
activity on HCC-1.2 cells. No difference in the pro-apoptotic activity of either test 
material was found; therefore, the commercial permethrin lot was used for all 
further experiments 
As to the mechanism(s) underlying the pro-apoptotic action of permethrin on 
hepatocytes, Gassner et al. (1997) suggested that permethrin blocks 
mitochondrial complex I and consequently, cytotoxicity might involve ROS 
formation and disturbance of energy supply. Meanwhile, the specific targeting of 
complex I by permethrin has been challenged. Thus, recent studies on 
submitochondrial particles in mitochondrial bovine heart by Staniek, Bicker and 
Bursch [personal communication] strongly suggest a permethrin action 
downstream of complex I, involving inhibition of the NADH-oxidase– activity. 
Notably, the permethrin phase I metabolites permethrinic acid, 3-phenoxybenzyl 
alcohol and 3 phenoxybenzoic acid did not inhibit NADH-oxidase-activity in 
submitochondrial particles [STANIEK, BICKER, BURSCH, unpublished 
observations, personal communication]. This is in line the results of the present 
study, revealing a reduced or even lacking pro-apoptotic potency of permethrin 
metabolites as compared to the parent compound.   
In summary, permethrin seem to cause apoptosis via inhibition of mitochondrial 
respiration, which in turn is known to result in permeabilisation of the outer 
mitochondrial membrane (OMM), finally leading to apoptosis execution via the 
intrinsic apoptotic pathway. As the pro-apoptotic action of TGF-β1 is mediated 
via the same pathway down to final apoptosis execution, the initial events 
triggered by permethrin and TGF-β1 may well join at the mitochondrial level, 
thereby providing a plausible explanation for their additive effect on apoptosis 
(fig. 5.1.). 
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Fig. 5.1 Stereoselectivity of effects caused by permethrin 
 
 
Finally, the pro-apoptotic potency of the four-isomer mixture of permethrin as 
well as that of its stereoisomers [(trans(+)-(1S,3R)- permethrin (11-permethrin); 
trans(-)-(1R,3S) permethrin (12-permethrin); cis(-)-(1S,3S) permethrin (21-
permethrin); Cis(+)-(1R,3R) permethrin (22-permethrin)] essentially revealed 
to be equal, as opposed to the insecticidal action of permethrin based upon its 
interaction with ion-channels. The present study along with the currently 
ongoing studies by Staniek, Bicker and Bursch suggest that permethrin 
primarily targets the mitochondrial respiratory chain independent of its 
stereochemistry and thereby, triggers apoptosis (fig. 5.1). At the current state of 
knowledge, however, potential stereoselective interactions of permethrin with 
other initial target molecules cannot be ruled out, but if occurring, the final 
outcome seems to be dominated by mitochondrial events leading to apoptosis 
execution.  
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6 CONCLUSION 
 
 
The present study revealed the following results:  
 
(a) The newly established hepatoma cell line HCC-1.2 exhibits (1) a high 
sensitivity towards the anti-proliferative and pro-apoptotic action of TGF-
β1; (2) inhibition of TGF-β1-induced apoptosis by liver tumor promoter, 
as exemplified by Phenobarbital.  
(b) The commercial four-isomer mixture (cis-racemate / trans-racemate ~ 
25/75) exhibited a dose-dependent pro-apoptotic effect.  
(c) Joint application of permethrin with TGF-β1 led to an additive effect on 
apoptosis in HCC-1.2. 
(d) The apoptosis-inducing action of the commercial permethrin mixture and 
that of highly purified permethrin did not differ, rendering impurities of 
the commercial batch most unlikely to account for its pro-apoptotic 
potency.  
(e) As compared to HCC-1.2 cells, Hep3B cells exhibited only a weak 
response to permethrin under the experimental conditions used (50µM, 
24 and 48 hours). In cultured primary rat hepatocytes, permethrin alone 
did not exhibit a pro-apoptotic effect; the data on combined treatment 
with TGF-β1 do not allow a final conclusion yet. 
(f) The pro-apoptotic potency of permethrin was largely reduced upon 
metabolism to main phase I metabolites. 
(g) The permethrin stereoisomers (1R,cis, 1S,cis, 1R,trans and 1S, trans) 
did not exhibit pronounced differences in their pro-apoptotic action on 
HCC1-2 cells. 
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In conclusion, HCC-1.2 cell are considered to provide a usefull human liver cell 
culture system, based upon its ability to detect known in vivo activities of TGF-
β1 and phenobarbital. Furthermore, permethrin was found to posses a pro-
apoptotic activity on human hepatoma cells (HCC-1.2), additive to TGF-β1. 
Most probably, the pro-apoptotic signalling cascades triggered by TGF-β1 and 
permethrin join at the level of mitochondria. In contrast to the neurotoxic 
(insecticidal) action of permethrin, the pro-apoptotic action on liver cells was 
found not to dependent on the stereoisomeric properties of the chemical. 
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7 SUMMARY 
 
Stereochemistry plays a crucial role in determining the toxicological profile of 
many chiral xenobiotics.  For instance, the insecticidal (neurotoxic) action of 
permethrin based upon interaction with sodium-channels is highly 
stereoselective, with 1R-isomers being much more toxic than 1S-isomers. 
However, studies on the toxicity of permethrin in other target organs such the 
liver were carried out with the isomer mixture of permethrin only. Therefore, the 
present project was initiated to shed light on stereoselectivity of non-neurotoxic 
profile of permethrin and its stereoisomers in mammalian cells. The present 
diploma thesis addresses two topics: 
1. the validity of newly established human hepatoma cell line HCC-1-2 for 
toxicity studies 
2. the action of commercial four-isomer mixture and stereosisomers on 
hepatocellular apoptosis. 
1. Experimental models: 
(a) two established cell culture models, namely primary rat hepatocytes and the 
human hepatoma cell line Hep3B  
(b) a newly established hepatoma cell line HCC-1.2 [SAGMEISTER et al., in 
press; KARWAN et al., 2007; BURSCH et al., 2008]. 
2. Substances tested: 
(a) commercial four-isomer mixture (cis-racemate / trans-racemate ~ 25/75) 
(b) permethrin isomers: (trans(+)-(1S,3R)- permethrin (11-permethrin); trans(-
)-(1R,3S) permethrin (12-permethrin); cis(-)-(1S,3S) permethrin (21-
permethrin); Cis(+)-(1R,3R) permethrin (22-permethrin) 
(c) phase I metabolites of permethrin: permethrinic acid, 3-phenoxybenzyl 
alcohol, and 3-phenoxybenzoic acid. 
3. Morphological detection of apoptosis:  
chromatin condensation/fragmentation as visualized by the DNA specific stain 
H33258. 
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4. Results  
(a) The newly established hepatoma cell line HCC-1.2 exhibits (1) a high 
sensitivity towards the anti-proliferative and pro-apoptotic action of TGF-β1; 
(2) inhibition of TGF-β1-induced apoptosis by liver tumor promoter, as 
exemplified by Phenobarbital. Furthermore, Karwan et al. (2007) have 
shown that TGF-β1 induced apoptosis of HCC-1.2 cells is mediated via the 
intrinsic pathway.  
(b) The commercial four-isomer mixture (cis-racemate / trans-racemate ~ 
25/75) exhibited a dose-dependent pro-apoptotic effect.  
(c) Joint application of permethrin with TGF-β1 led to an additive effect on 
apoptosis in HCC-1.2. 
(d) The apoptosis-inducing action of the commercial permethrin mixture and 
that of highly purified permethrin did not differ, rendering impurities of the 
commercial batch most unlikely to account for its pro-apoptotic potency.  
(e) As compared to HCC-1.2 cells, Hep3B cells exhibited only a weak response 
to permethrin under the experimental conditions used (50µM, 24 and 48 
hours). In cultured primary rat hepatocytes, permethrin alone did not exhibit 
a pro-apoptotic effect; the data on combined treatment with TGF-β1 do not 
allow a final conclusion yet. 
(f) The pro-apoptotic potency of permethrin was largely reduced upon 
metabolism to main phase I metabolites. 
(g) The permethrin stereoisomers (1R,cis, 1S,cis, 1R,trans and 1S,trans) did 
not exhibit pronounced differences in their pro-apoptotic action on HCC1-2 
cells. 
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Zusammenfassung 
Stereochemie spielt bei der Ermittlung des toxikologischen Profils eine äußerst 
wichtige Rolle. Die neurotoxische Wirkung von Permethrin, basierend auf 
Interaktionen mit Natrium-Kanälen, ist stark von der Stereochemie beeinflusst. 
1R-Isomere zeigen eine deutlich höhere toxische Wirkung verglichen zu den 
1S-Isomeren. Studien, die jedoch andere Zielorgane untersuchten, wurden nur 
mit der Vier-Isomer Mischung von Permethrin durchgeführt. Ziel dieses 
Projektes ist die selektive Wirkung von Permethrin-Stereoisomern in 
Säugetierzellen zu untersuchen.  
Diese Diplomarbeit behandelt  zwei Themen: 
1. Die Validierung einer neu etablierten humanen Hepatom-Zelllinie (HCC-1.2) 
für toxikologische Studien und 
2. die Wirkung einer kommerziell erhältlichen Vier-Isomer Mischung  von 
Permethrin bzw. Permethrin-Stereoismeren auf hepatozelluläre Apoptosis. 
1. Experimentelle Ausführung: 
(a) Zwei etablierte Zellkultur Modelle: primäre Rattenhepatozyten und die 
menschliche Hepatom-Zelllinie Hep3B und 
(b) die neu etablierte Hepatom-Zelllinie HCC-1.2. 
2. Getestete Substanzen: 
(a) die Vier-Isomer Mischung von Permethrin [cis-Racemat / trans-Racemat ~ 
25/75] 
(b) Permethrin Stereoisomere [(trans(+)-(1S,3R)- Permethrin; trans(-)-(1R,3S) 
Permethrin; cis(-)-(1S,3S) Permethrin; Cis(+)-(1R,3R) Permethrin] 
(c) Phase I Metaboliten: Permethrinsäure, 3-Phenoxabenzylalkohol and 3-
Phenoxybenzoesäure 
3. Morpholgische Auswertung der Apoptose: 
Chromatin Kondensation/Fragmention visualisiert mittels des DNA spezifischen 
Farbstoff H33258. 
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4. Resultate: 
(a) Die neu etablierte Hepatom-Zelllinie HCC-1.2 zeigt eine hohe Sensitivität  
gegenüber der anti-proliferativen  und pro-apoptotischen Wirkung von TGF-
β1 sowie der Hemmung von TGF-β1 induzierter Apoptose durch 
Tumorpromotoren am Beispiel von Phenobarbital.  
(b) Die Vier-Isomer Mischung von Permethrin weist eine dosisabhängige pro-
apoptotische Wirkung auf. 
(c) Die gemeinsame Behandlung von Permethrin und TGF-β1 führt zu einem 
additiven Effekt in HCC-1.2. 
(d) Zwischen der kommerziell erhältlichen Permethrin Mischung  und dem hoch 
gereinigten Permethrin bestehen keine Unterschiede in der pro-
apoptotischen Wirkung.  Verunreinigungen sollten daher keinen Einfluss auf 
die pro-apoptotische Wirkung von Permethrin haben. 
(e) Verglichen zu HCC-1.2 Zellen weisen Hep3B und primäre 
Rattenhepatozyten nur eine schwache Reaktion gegenüber der Behandlung 
mit Permethrin auf. 
(f) Die pro-apoptotische Wirkung von Permethrin wurde größtenteils durch den 
Phase I Metabolismus reduziert. 
(g) Die Permethrin-Stereoismere weisen keine signifikanten Unterschiede in 
der pro-apoptotischen Wirkung auf. 
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8 APPENDIX 
 
Tables  
 
Tab. 8.1 Apoptosis rate of HCC-1.2 cells after 24 h and 48 h, respectively, cultivation with 
10 ng/ml TGF-β1 (Fig. 4.1 a-e). 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 24h (n=15) 1.5 ± 1.0 1 
TGF-β1 24h (n=15) 7.1 ± 3.4 5.6 ± 2.5 
Control 48h (n=12) 1.8 ± 1.2 1.5 ± 0.7 
TGF-β1 48h (n=12) 10.8 ± 2.7 10.6 ± 4.6 
 
 Mitosis 
Mean (%) 
Mitosis 
x-fold 
Cell density 
Mean 
Control 24h (n=15) 2.5 ± 0.7 1 151 ± 78 
TGF-β1 24h  (n=15) 1.6 ± 0.7 0.7 ± 0.3 100 ± 52 
Control 48h (n=12) 1.5 ± 0.6 0.6 ± 0.3 142 ± 66 
TGF-β1 48h (n=12) 1.1 ± 0.8 0.4 ± 0.3 60 ± 27 
 
 
Tab. 8.2 Response of HCC-1.2 to 1µM, 25µM, 50µM and 100µM phenobarbital (PB) and 10 
ng/ml TGF-β1 after 24h and 48h (Fig. 4.2 a-e ). 
 Apoptosis 
Mean (%) 
 Apoptosis 
Mean (%) 
TGF-β1 24h (n=8) 7.2 ± 3.9 100µM PB TGF-β1 24h (n=2) 3.9 ± 0.7 
TGF-β1 48h (n=8) 11.4 ± 2.4 1µM PB TGF-β1 48h (n=2) 9.2 ± 0.4 
1µM PB TGF-β1 24h (n=2) 6.0 ± 1.9 25µM PB TGF-β1 48h (n=3) 6.0  ± 1.3 
25µM PB TGF-β1 24h  (n=3) 4.3 ± 1.5 50µM PB TGF-β1 48h (n=6) 5.7 ± 1.2 
50µM PB TGF-β1 24h  (n=6) 3.7  ± 1.1 100µM PB TGF-β1 48h (n=2) 6.0 ± 1.8 
 Apoptosis 
(x-fold) 
 Apoptosis 
(x-fold) 
TGF-β1 24h (n=8) 5.4 ± 2.7 100µM PB TGF-β1 24h (n=2) 6.5 ± 1.1 
TGF-β1 48h (n=8) 10.0 ± 5.6 1µM PB TGF-β1 48h (n=2) 11.1 ± 5.4 
1µM PB TGF-β1 24h (n=2) 6.7 ± 1.4 25µM PB TGF-β1 48h (n=3) 7.1  ± 4.6 
25µM PB TGF-β1 24h  (n=3) 4.3 ± 1.4 50µM PB TGF-β1 48h (n=6) 4.5 ± 3.6 
50µM PB TGF-β1 24h  (n=6) 2.7  ± 1.5 100µM PB TGF-β1 48h (n=2) 10.0 ± 3.0 
  
 Mitosis 
Mean (%) 
Mitosis 
x-fold 
Cell density 
Mean (%) 
Control 24h (n=6) 2.5 ± 0.7 1  138 ± 4 
50µM PB 24h (n=6) 2.5 ± 0.5 1.0 ± 0.3 125 ± 55 
TGF-β1 24h (n=6) 1.7 ± 0.4 0.7 ± 0.2 92 ± 48 
50µM PB TGF-β1 24h (n=6)  2.1 ± 0.7 0.8 ± 0.4 112 ± 57 
Control 48h (n=6) 1.5 ± 0.4 0.6 ± 0.2 146 ± 74 
50µM PB 48h (n=6) 1.6 ± 0.6 0.7 ± 0.3 132 ± 74 
TGF-β1 48h (n=6) 1.0 ± 0.5 0.4 ± 0.2 58 ± 23 
50µM PB TGF-β1 48h (n=6)  1.2 ± 0.7 0.5 ± 0.3 69 ± 19 
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Tab. 8.3 Response of Hep3B cells to 50µM phenobarbital (PB) and 10 ng/ml TGF-β1 after 
24h and 48h (Fig. 4.3 a-e). 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 24h (n=2) 2.0 ± 0.3 1 
50µM PB 24h (n=2) 3.4 ± 0.9 1.7 ± 0.5 
TGF-β1 24h (n=2) 6.2 ± 1.6 3.1 ± 0.9 
TGF-β1+ 50µM PB 24h (n=2) 2.8 ± 0.4 1.4 ± 0.1 
Control 48h (n=1) 3.7; 4.5  1.8; 2.2 
50µM PB 48h (n=1)  5.2; 6.6  2.5; 3.2 
TGF-β1 48h (n=1)  9.1; 9.1  4.4; 4.4 
TGF-β1+ 50µM PB 48h (n=1)  4.2; 3.7  2.0;1.8 
 
 
Tab. 8.4 Response of primary rat hepatocytes to 3ng/ml TGF-β1, 50µM phenobarbital (PB) 
after 30h and 44h (n=2) (Fig. 4.4 a-e). 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 30h  0.45 ± 0.15 1 
50µM PB 30h  0.35 ± 0.24 0.78 ± 0.53 
TGF-β1 30h  7.46 ± 0.47 16.65 ± 0.63 
TGF-β1+ 50µM PB 30h  3.94 ± 1.11 8.75 ± 2.26 
Control 44h  0.22 ±0.14  0.50 ±0.28  
50µM PB 44h 0.33 ± 0.29 0.80 ± 0.57 
TGF-β1 44h 5.09 ± 0.53 11.43 ± 1.45 
TGF-β1+ 50µM PB 44h 3.07 ± 1.25 6.85 ± 0.42 
 
 Mitosis Mean (%) 
Mitosis 
x-fold 
Cell density 
Mean 
Control 30h  0.15 ± 0.06 1 167 ± 16 
50µM PB 30h 0.12 ± 0.17 1.09 ± 1.54 170 ± 15 
TGF-β1 30h 0.17 ± 0.02 1.21 ± 0.63 71 ± 4 
TGF-β1+ 50µM PB 30h 0.27 ± 0.08 2.05 ± 1.34 82 ± 16 
Control 44h 0.10 ± 0.08 0.84 ± 0.87  130 ± 13 
50µM PB 44h 0.21 ± 0.03 1.42 ± 0.38 126 ± 19 
TGF-β1 44h 0.15 ± 0.09 0.96 ± 0.20 53 ± 10 
TGF-β1+ 50µM PB 44h 0.36 ± 0.37 2.00 ± 1.67 81 ± 21 
 
 Mitosis 
Mean (%) 
Mitosis 
x-fold 
Cell density 
Mean  
Control 24h (n=2) 2.7 ± 0.5 1 105 ± 7 
50µM PB 24h (n=2) 2.7 ± 0.7 1.0 ± 0.1 95 ± 5 
TGF-β1 24h (n=2) 2.3 ± 0.8 0.9 ± 0.1 85 ± 10 
TGF-β1+ 50µM PB 24h (n=2) 1.9 ± 1.4 0.7 ± 0.4 98 ± 8 
Control 48h (n=1) 1.2; 0.9 0.5; 0.4 101; 100 
50µM PB 48h (n=1) 0.7; 0.4 0.3; 0.2 77; 72 
TGF-β1 48h (n=1) 0.7; 0.3 0.3; 0.1 54; 55 
TGF-β1+ 50µM PB 48h (n=1) 0.1; 0.2 0.0; 0.1 140; 76 
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Tab. 8.5 Response of HCC-1.2 to 25µM, 50µM commercial permethrin (Per) and 10 ng/ml 
TGF-β1 after 24h and 48h (Fig. 4.5 a-d). 
 
 
 
 
Tab. 8.6 Response of HCC-1.2 to commercial permethrin (P commercial), permethrin pure 
(P pure) and TGF-β1 after 24 and 48 hours (n=2) (Fig. 4.7 a-d). 
 24 h 
Apoptosis 
Mean (%) 
48 h 
Apoptosis 
Mean (%) 
24 h 
Apoptosis 
x-fold 
48 h 
Apoptosis 
x-fold 
Control  0.9 ± 0.2 1.2 ± 1.4 1 1,2 ± 1,4 
25µM P commercial  1.5 ± 0.1 1.0 ± 0.7 1.8 ± 0.4 1.1 ± 0.5 
25 µM P pure  2.4 ± 0.4 1.7 ± 0.6 2.9 ± 0.2 2.0 ± 0.2 
50µM P commercial 2.0 ± 0.4 1.4 ± 0.7 2.4 ± 1.0 1.6 ± 0.4 
50µM P pure  2.0 ± 0.3 2.1 ± 0.2 2.4 ± 1.3 2.6 ± 0.8 
TGF-β1 7.1 ± 0.7 9.2 ± 0.3 8.6 ± 1.3 11.1 ± 2.4 
25µM P commercial + TGF-β1 8.9 ± 1.2 13.4 ± 0.7 10.6 ± 1.2 16.1 ± 3.2 
25 µM P pure + TGF-β1 8.8 ± 0.4 13.3 ± 2.2 10.8 ± 3.2 16.5 ± 6.7 
50µM P commercial + TGF-β1 10.6 ± 1.5 14.6 ± 3.6 12.7 ± 1.4 17.2 ± 0.1 
50µM P pure + TGF-β1 12.0 ± 1.2 15.2 ± 1.9 14.4 ± 2.2 18.2 ± 2.3 
 
 
 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 24h (n=10) 1.7 ± 1.0 1 
25µM Per 24h (n=4) 2.1 ± 1.6 2.1 ± 0.9 
50µM Per 24h (n=10) 4.1 ± 2.1 2.7 ± 1.0 
TGF-β1 24h (n=10) 7.5 ± 3.3 5.3 ± 2.6 
25µM Per TGF-β1 24h (n=4) 8.7 ± 2.1 9.9 ± 1.3 
50µM Per TGF-β1 24h (n=10) 14.1 ± 5.7 9.9 ± 3.0  
Control 48h (n=7) 2.1 ± 1.4 1.4 ± 0.8 
25µM Per 48h (n=4) 2.8 ± 2.1 2.0 ± 1.2 
50µM Per 48h (n=7) 3.8 ± 3.0 2.6 ± 1.5 
TGF-β1 48h (n=7) 11.9 ± 2.2 9.3 ± 4.9 
25µM Per TGF-β1 48h (n=4) 12.4 ± 2.1 14.5 ± 3.4 
50µM Per TGF-β1 48h (n=7) 15.0 ± 2.8 12.7 ± 5.3 
 Mitosis 
Mean (%) 
Cell density 
Mean 
Control 24h (n=10) 2.7 ± 0.7 129 ± 43 
50µM Per 24h (n=10) 2.2 ± 0.6 118 ± 46 
TGF-β1 24h (n=10) 1.8 ± 0.3 90 ± 41 
TGF-β1 + 50µM Per  24h (n=10) 1.5 ± 0.5 80 ± 24 
Control 48h (n=7) 1.5 ± 0.3 143 ± 70 
50µM Per 48h (n=7) 1.2 ± 0.7 113 ± 50 
TGF-β1 48h (n=7) 1.1 ± 0.5 61 ± 22 
TGF-β1 + 50µM Per 48h (n=7) 1.1 ± 0.7 52 ± 17 
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Tab. 8.7 Effect of 50 µM commercial permethrin (P) and 10ng/ml TGF-β1 in HCC-1.2 and 
Hep3B cells after 24 hours and the effect of 50 µM permethrin (P) and 3ng/ml TGF-β1 in 
primary rat hepatocytes after 30 hours (Fig. 4.8 a-d). 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 24h (HCC-1.2) (n=10) 1.7 ± 1.0 1.0 
50µM P 24h(HCC-1.2) (n=10) 4,2 ± 2,2 2,7 ± 1,0 
TGF-β1 24h (HCC-1.2) (n=10) 7.5 ± 3.3 5.3 ± 2.6 
TGF-β1+ 50µM P 24h(HCC-1.2) (n=10) 14.1 ± 5.7 9.9 ± 3.0 
Control 24h (Hep3B) (n=2) 2.0 ± 0.0 1.0  
50µM P 24h (Hep3B) (n=2) 4,0 ± 0,4 2,0 ± 0,3 
TGF-β1 24h (Hep3B) (n=2) 6.2 ± 1.7 3.1 ± 0.9 
TGF-β1+ 50µM P 24h (Hep3B) (n=2) 6.2 ± 1.2 3.1 ± 0.7 
Control 30h (primary rat hepatocytes) (n=2) 0.45 ± 1.01 1.0 
50µM P 30h (primary rat hepatocytes) (n=2) 0,41 ± 0,30 0,93 ± 0,67 
TGF-β1 30h (primary rat hepatocytes) (n=2) 7.46 ± 0.47 16.70 ± 0.64 
TGF-β1+ 50µM P 30h (primary rat hepatocytes) (n=2) 9.01 ± 1.38 20.10 ± 2.62 
 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 48h (HCC-1.2) (n=7) 2.1 ± 1.5 1.4 ± 0.9 
50µM P 48h(HCC-1.2) (n=7) 3,4 ± 3,3 2,6 ± 1,5 
TGF-β1 48h (HCC-1.2) (n=7) 11.7 ± 2.2 9.5 ± 5.3 
TGF-β1 + 50µM P 48h(HCC-1.2) (n=7) 15.0 ± 2.8 12.7 ± 5.3 
Control 48h (Hep3B) (n=1) 3.7; 4.5 1.8; 2.2 
50µM P 48h (Hep3B) (n=1) 5.0¸8.6 2.5; 4.3 
TGF-β1 48h (Hep3B) (n=1) 9.1; 9.1 4.4; 4.4 
TGF-β1+ 50µM P 48h (Hep3B) (n=1) 8.4; 6.2 2.0; 1.8 
Control 44h (primary rat hepatocytes) (n=2) 0.22 ± 1.14 0.50  0.28 
50µM P 44h (primary rat hepatocytes) (n=2) 0,30 ± 0,09 0,67 ± 0,18 
TGF-β1 44h (primary rat hepatocytes) (n=2) 5.09 ± 0.53 11.43 ± 1.45 
TGF-β1+ 50µM P 44h (primary rat hepatocytes) (n=2) 13.60 ±1.78 30.40 ± 3.04 
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Tab. 8.8 HCC-1.2 treated with 10ng/ml TGF-β1, 50µM permethrin and permethrin-
stereoisomers (2 µM, 10 µM and 50 µM) for 24 hours (Fig. 4.9 a-d). 
 11-Per 
Apoptosis 
Mean (%) 
11-Per 
Apoptosis 
x-fold  
12-Per 
Apoptosis 
Mean (%) 
12-Per 
Apoptosis 
x-fold  
Control (n=3) 2.0 ± 0.5 1 2.0 ± 0.5 1 
50µM Permethrin (commercial) (n=3) 4.8 ± 0.3 2.5 ± 0.5 4.8 ± 0.3 2.5 ± 0.5 
2µM Per-stereoisomer (n=2) 1.9 ± 0.2 0.9 ± 0.2 2.1 ± 1.3 1.0 ± 0.4 
10µM Per-stereoisomer  (n=3) 3.7 ± 0.9 1.9 ± 0.4 5.0 ± 2.3 2.7 ± 1.1 
50µM Per-stereoisomer (n=3) 4.6 ± 0.8 2.4 ± 0.5 6.0 ± 1.1 3.2  ±1.0 
TGF-β1 (n=3) 6.0 ± 1.4 3.1 ± 1.1 6.0 ± 1.4 3.1 ± 1.1 
50µM Permethrin (commercial) TGF-β1 
(n=3) 
15.8 ± 1.3 8.3 ± 1.7 15.8 ± 1.3 8.3 ± 1.7 
2µM Per-stereoisomer TGF-β1 (n=2) 7.9 ± 09 4.0 ± 1.5 9.5 ± 1.5 4.8 ± 2.0 
10µM Per-stereoisomer TGF-β1 (n=3) 10.1 ± 2.0 5.3 ± 1.8 10.2 ± 0.8 5.4 ± 1.5 
50µM Per-stereoisomer TGF-β1(n=3) 13.9 ± 3.0 7.3 ± 2.3 17.8 ± 2.7 9.5 ± 3.0 
 21-Per 
Apoptosis 
Mean (%) 
21-Per 
Apoptosis 
x-fold  
22-Per 
Apoptosis 
Mean (%) 
22-Per 
Apoptosis 
x-fold  
Control (n=3) 2.0 ± 0.5 1 2.0 ± 0.5 1 
50µM Permethrin (commercial) (n=3) 4.8 ± 0.3 2.5 ± 0.5 4.8 ± 0.3 2.5 ± 0.5 
2µM Per-stereoisomer (n=2) 3.8 ± 0.5 1,8 ± 0,2 3.8 ± 2.8 1.7 ± 0.9 
10µM Per-stereoisomer  (n=3) 5.0 ± 1.5 2.6 ± 0.6 3.7 ± 1.4 1.9 ± 0.2 
50µM Per-stereoisomer (n=3) 6.2 ± 2.4 3.3 ± 1.7 5.3 ± 4.5 2.5 ± 1.5 
TGF-β1 (n=3) 6.0 ± 1.4 3.1 ± 1.1 6.0 ± 1.4 3.1 ± 1.1 
50µM Permethrin (commercial) TGF-β1 
(n=3) 
15.8 ± 1.3 8.3 ± 1.7 15.8 ± 1.3 8.3 ± 1.7 
2µM Per-stereoisomer TGF-β1 (n=2) 8.8 ± 0.1 4.4 ± 1.5 7.8 ± 1.3 4.0 ± 1.6 
10µM Per-stereoisomer TGF-β1 (n=3) 13.7 ± 4.7 7.4 ± 3.1 14.7± 1.8 7.7 ± 1.8 
50µM Per-stereoisomer TGF-β1(n=3) 19.5 ± 2.2 10.5 ± 3.2 15.6 ± 2.2 8.2 ± 0.9 
 
 
 
Tab. 8.9 Response of HCC-1.2 to 0.1 µM, 1 µM and 10 µM rotenone (R) and 10 ng/ml TGF-
β1 after 24h and 48h (n=1) (Fig. 4.11). 
24 h Mean (%) 48h Mean (%) 
Control 0.8; 1.0 Control 1.6; 1.9 
0,1µM R 6.7; 3.6 0,1µM R 18.0; 12.1 
1µM R 7.1; 7.3 1µM R 17.2; 19.2 
10µM R 10.2; 6.2 10µM R 40.0; 27.7 
TGF-β1 5.8; 5.8 TGF-β1 10.4; 12.5 
0,1µM R TGF-β1 11.4; 12.0 0,1µM R TGF-β1 16.9; 12.2 
1µM R TGF-β1 13.8; 15.8 1µM R TGF-β1 16.9; 18.8 
10µM R TGF-β1 15.0; 20.4 10µM R TGF-β1 28.4; 35.6 
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Tab. 8.10 HCC-1.2 treated with 10 ng/ml TGF-β1 50 µM permethrin, 50 µM phenobarbital, 1 
µM rotenone, 50 µM 3-permethrinic acid (PA), 50 µM 3-phenoxybenzyl alcohol (PBOH) 
and 50 µM 3-phenoxybenzoic acid (PBA) for 24 hours and 48 hours (n=3) (Fig. 12 a-d). 
24h Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 2.4 ± 1.4 1 TGF-β1  9.1 ± 5.0 3.9 ± 0.3 
50µM PB 2.8 ± 1.2 1.2 ± 0.5 50µM PB TGF-β1  4.6 ± 0.6 2.4 ± 1.3 
50µM Permethrin  5.0 ± 2.7  2.3 ± 0.9 50µM Permethrin TGF-
β1  
17.4 ± 9.2 8.0 ± 3.7 
1µM Rotenone  6.7 ± 2.6 3.5 ± 2.5 1µM Rotenone TGF-β1  12.5 ± 4.5 6.4 ± 4.6 
50µM PA  2.9 ± 1.4 1.3 ± 0.4 50µM PA TGF-β1  7.4 ± 0.9 3.9 ± 2.0 
50µM PBOH  3.8 ± 2.2 1.6 ± 0.5 50µM PBOH TGF-β1  12.6 ± 1.6 6.5 ± 3.2 
50µM PBA 3.1 ± 1.1 1.6 ± 1.1 50µM PBA TGF-β1  7.5 ± 4.1 3.1 ± 1.1 
 
48h Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
 Apoptosis 
Mean (%) 
Apoptosis 
x-fold 
Control 3.1 ± 1.8 1.5 ± 1.1 TGF-β1  12.9 ± 2.2 5.2 ± 3.0 
50µM PB 4.2 ± 2.8 2.0 ± 1.4 50µM PB TGF-β1  5.7 ± 1.3 2.8 ± 1.1 
50µM Permethrin  5.0 ± 3.1 2.3 ± 1.1 50µM Permethrin TGF-
β1  
15.0 ± 1.1 7.7 ± 4.0 
1µM Rotenone  14.2 ± 4.9 7.2 ± 4.7 1µM Rotenone TGF-β1  15.0 ± 1.1 6.2 ± 1.3 
50µM PA  3.9 ± 2.8 1.9 ± 1.5 50µM PA TGF-β1  11.1 ± 2.2 6.2 ± 4.6 
50µM PBOH  3.5 ± 2.7 1.5 ± 0.6 50µM PBOH TGF-β1  10.8  ± 1.8 5.6 ± 3.3 
50µM PBA 3.1 ± 1.6 1.6 ± 1.2 50µM PBA TGF-β1  9.4 ± 1.3 4.9 ± 2.9 
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